Exclusively genital psoriasis successfully treated with Risankizumab

Dermatol Ther. 2022 Aug;35(8):e15591. doi: 10.1111/dth.15591. Epub 2022 Jun 6.

Authors

Gabriele Ceccarelli¹, Marco Simonacci¹

Affiliation

¹ Dermatology Unit, Macerata General Hospital, Macerata, Italy.

PMID: 35598296
DOI: 10.1111/dth.15591

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal
Genitalia
Humans
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Severity of Illness Index
Treatment Outcome

Substances

Antibodies, Monoclonal
risankizumab